Yuki Tsurinaga
Overview
Explore the profile of Yuki Tsurinaga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawabe T, Kawashima K, Nagai Y, Okuno M, Hanada Y, Yamaguchi T, et al.
Auris Nasus Larynx
. 2024 Oct;
51(6):1031-1036.
PMID: 39476784
Objective: This study aimed to determine the effectiveness of sublingual immunotherapy (SLIT) in preventing the exacerbation of asthma. Methods: This retrospective study investigated the changes in the rate of continuous...
2.
Xu Y, Tsurinaga Y, Matsumoto T, Muta R, Yano T, Sakaida H, et al.
Case Rep Genet
. 2024 Aug;
2024:1595717.
PMID: 39156004
Primary ciliary dyskinesia (PCD) is a hereditary disease caused by genes related to motile cilia. We report two male pediatric cases of PCD caused by hemizygous pathogenic variants in the...
3.
Korematsu S, Fujisawa T, Saito N, Tezuka J, Miura K, Kobayashi I, et al.
Clin Transl Allergy
. 2024 Jan;
14(1):e12330.
PMID: 38282201
Background: Acute asthma exacerbation in children is often caused by respiratory infections. In this study, a coordinated national surveillance system for acute asthma hospitalizations and causative respiratory infections was established....
4.
Kawabe T, Kawashima K, Okuno M, Yamamoto M, Sasaki T, Hanada Y, et al.
Arerugi
. 2023 Jun;
72(4):375-387.
PMID: 37316242
Background: Sublingual immunotherapy (SLIT) has become applicable to insurance for children in Japan in 2018. However, as for the efficacy of SLIT for children, objective evaluation methods have not been...
5.
Takaoka Y, Ito Y, Kumon J, Yamaguchi T, Ueno R, Tsurinaga Y, et al.
Asian Pac J Allergy Immunol
. 2023 Apr;
PMID: 37061933
Background: Low-dose oral immunotherapy (OIT) is a safe treatment for hen's egg allergy; however, comparison of its therapeutic effects with those of high-dose OIT has not been reported. Objective: To...
6.
Yoshida Y, Fukasawa Y, Kumon J, Yamaguchi T, Ueno R, Tsurinaga Y, et al.
Arerugi
. 2022 May;
71(3):221-230.
PMID: 35569944
Background: Lung function in early-period school-aged children with asthma influences remission in adolescence. However, there are no reports of this in Japan. Objective: This study investigated the influence of lung...
7.
Takaoka Y, Yajima Y, Ito Y, Kumon J, Muroya T, Tsurinaga Y, et al.
Int Arch Allergy Immunol
. 2020 Jun;
181(9):699-705.
PMID: 32570237
Introduction: Oral immunotherapy (OIT) has been reported to be effective but associated with a risk of severe symptoms. Thus, an OIT method with decreased risk is required. Objectives: We aimed...
8.
Takaoka Y, Maeta A, Takahashi K, Ito Y, Takahashi S, Muroya T, et al.
Int Arch Allergy Immunol
. 2019 Oct;
180(4):244-249.
PMID: 31578023
Introduction: The usefulness of low-dose oral immunotherapy (OIT) for the treatment of egg allergy has been unclear. Objective: To evaluate the efficacy and safety of OIT with low allergen cookies...
9.
Yoshida H, Onohara K, Tazawa T, Kawahara K, Tsurinaga Y, Han Y, et al.
Kekkaku
. 2015 Oct;
90(5):497-502.
PMID: 26489153
Objective: To evaluate the efficiency of the direct tuberculosis-loop-mediated isothermal amplification (TB-LAMP) assay by using non-centrifuged sputum samples. STUDY PERIOD AND METHODS: The study was conducted between June 2013 and...
10.
Yoshida H, Onohara K, Tazawa T, Tsurinaga Y, Kurokawa M, Han Y, et al.
Kekkaku
. 2014 Jan;
88(11):727-33.
PMID: 24432481
Unlabelled: OBJECTIVE; The COBAS TaqMan real-time polymerase chain reaction (PCR) assay (TaqMan assay) is a well-accepted and widely distributed molecular-based diagnostic test for tuberculosis. In the present study, we evaluated...